期刊
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
卷 413, 期 11, 页码 2943-2949出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00216-021-03227-5
关键词
POCT; Microfluidic; GMR; Biosensor; NT-proBNP
资金
- Chalmers University of Technology
- National Key Technology R&D Program of China [2013BAI03B03]
- Medical and Health Science and Technology Project of Shandong Province [2017WS075, 202011000657]
- Innovation Project of Shandong Academy of Medical Sciences
A microfluidic sandwich immunoassay utilizing a dual-GMR sensor array was reported for quantifying heart failure biomarker NT-proBNP in human plasma, with a broad dynamic range and low detection limit. The system demonstrated the ability to accurately analyze samples from patients with different cardiovascular diseases, showing potential for practical use in point-of-care analysis due to its wide concentration range and short measurement time.
We report a microfluidic sandwich immunoassay constructed around a dual-giant magnetoresistance (GMR) sensor array to quantify the heart failure biomarker NT-proBNP in human plasma at the clinically relevant concentration levels between 15 pg/mL and 40 ng/mL. The broad dynamic range was achieved by differential coating of two identical GMR sensors operated in tandem, and combining two standard curves. The detection limit was determined as 5 pg/mL. The assay, involving 53 plasma samples from patients with different cardiovascular diseases, was validated against the Roche Cobas e411 analyzer. The salient features of this system are its wide concentration range, low detection limit, small sample volume requirement (50 mu L), and the need for a short measurement time of 15 min, making it a prospective candidate for practical use in point of care analysis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据